Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rex Wan-Hin Hui

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Hepatology International|February 17, 2025
Expanding treatment indications in chronic hepatitis B: Should we treat all patients?Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, et al.
Expert Opinion on Investigational Drugs|October 30, 2023
Bepirovirsen (GSK3228836) in chronic hepatitis B infection: an evaluation of phase II progressLung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.
Clinical and Molecular Hepatology|November 14, 2024
Prospect of emerging treatments for hepatitis B virus functional cureRex Wan-Hin Hui, Lung-Yi Mak, James Fung, et al.
Expert Review of Gastroenterology & Hepatology|March 27, 2023
Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapyRex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, et al.
Clinical and Molecular Hepatology|November 11, 2025
Targeting the innate immune system in treating hepatitis B: Prospects for functional cureKaren Cheuk-Ying Ho, Rex Wan-Hin Hui, Wai-Kay Seto, et al.
Expert Opinion on Drug Discovery|March 21, 2023
Advances in determining new treatments for hepatitis B infection by utilizing existing and novel biomarkersLung-Yi Mak, Rex Wan-Hin Hui, Ka-Shing Cheung, et al.
Journal of Viral Hepatitis|March 15, 2025
Development and Validation of a High-Sensitivity Droplet Digital PCR Assay for Serum Hepatitis B Virus DNA DetectionRex Wan-Hin Hui, Danny Ka-Ho Wong, Lung-Yi Mak, et al.
F1000Research|May 20, 2024
Hepatocellular carcinoma: Advances in systemic therapiesTrevor Kwan-Hung Wu, Rex Wan-Hin Hui, Lung-Yi Mak, et al.
Journal of Gastroenterology and Hepatology|October 5, 2023
Plasma interferon-gamma-inducible-protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patientsKarin Kan, Danny Ka-Ho Wong, Rex Wan-Hin Hui, et al.
BMC Gastroenterology|October 6, 2023
Anti-HBc: a significant host predictor of spontaneous HBsAg seroclearance in chronic hepatitis B patients - a retrospective longitudinal studyKarin Kan, Danny Ka-Ho Wong, Rex Wan-Hin Hui, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Hepatology International|February 17, 2025
Expanding treatment indications in chronic hepatitis B: Should we treat all patients?Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, et al.
Expert Opinion on Investigational Drugs|October 30, 2023
Bepirovirsen (GSK3228836) in chronic hepatitis B infection: an evaluation of phase II progressLung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.
Clinical and Molecular Hepatology|November 14, 2024
Prospect of emerging treatments for hepatitis B virus functional cureRex Wan-Hin Hui, Lung-Yi Mak, James Fung, et al.
Expert Review of Gastroenterology & Hepatology|March 27, 2023
Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapyRex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, et al.
Clinical and Molecular Hepatology|November 11, 2025
Targeting the innate immune system in treating hepatitis B: Prospects for functional cureKaren Cheuk-Ying Ho, Rex Wan-Hin Hui, Wai-Kay Seto, et al.
Expert Opinion on Drug Discovery|March 21, 2023
Advances in determining new treatments for hepatitis B infection by utilizing existing and novel biomarkersLung-Yi Mak, Rex Wan-Hin Hui, Ka-Shing Cheung, et al.
Journal of Viral Hepatitis|March 15, 2025
Development and Validation of a High-Sensitivity Droplet Digital PCR Assay for Serum Hepatitis B Virus DNA DetectionRex Wan-Hin Hui, Danny Ka-Ho Wong, Lung-Yi Mak, et al.
F1000Research|May 20, 2024
Hepatocellular carcinoma: Advances in systemic therapiesTrevor Kwan-Hung Wu, Rex Wan-Hin Hui, Lung-Yi Mak, et al.
Journal of Gastroenterology and Hepatology|October 5, 2023
Plasma interferon-gamma-inducible-protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patientsKarin Kan, Danny Ka-Ho Wong, Rex Wan-Hin Hui, et al.
BMC Gastroenterology|October 6, 2023
Anti-HBc: a significant host predictor of spontaneous HBsAg seroclearance in chronic hepatitis B patients - a retrospective longitudinal studyKarin Kan, Danny Ka-Ho Wong, Rex Wan-Hin Hui, et al.
Pageof 6